We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Inotiv

News List

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® Portfolio americanpharmaceuticalreview
July 13, 2021
Inotiv acquired genetic toxicology assets from MilliporeSigma’s BioReliance® portfolio, including standard operating procedures, stock cultures, historic control data and client list.
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program prnewswire
March 19, 2021
BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and cancer applications, announced that it has entered into an agreement with Bioanalytical Systems, Inc. d/b/a Inotiv, a global Contract Research Organization ...